Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126338091 | 12633809 | 1 | I | 2014 | 20150420 | 20160808 | 20160808 | EXP | CA-PFIZER INC-2015138710 | PFIZER | 60.00 | YR | F | Y | 70.00000 | KG | 20160808 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126338091 | 12633809 | 1 | PS | SOMAVERT | PEGVISOMANT | 1 | Subcutaneous | 10 MG, 1X/DAY | 21106 | 10 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QD | ||||||
| 126338091 | 12633809 | 2 | SS | SOMAVERT | PEGVISOMANT | 1 | Subcutaneous | 15 MG, 1X/DAY | 21106 | 15 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QD | ||||||
| 126338091 | 12633809 | 3 | SS | HCTZ | HYDROCHLOROTHIAZIDE | 1 | 25 MG, 1X/DAY | Y | 0 | 25 | MG | QD | |||||||
| 126338091 | 12633809 | 4 | C | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | 20 MG, MONTHLY | 0 | 20 | MG | /month | ||||||||
| 126338091 | 12633809 | 5 | C | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, MONTHLY | 0 | 40 | MG | /month | |||||||
| 126338091 | 12633809 | 6 | C | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | 20 ML, MONTHLY (SHOT) | 0 | 20 | ML | /month | ||||||||
| 126338091 | 12633809 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0.1 MG, 1X/DAY | 0 | .1 | MG | QD | ||||||||
| 126338091 | 12633809 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
| 126338091 | 12633809 | 9 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 126338091 | 12633809 | 10 | C | ASA | ASPIRIN | 1 | 81 MG, 1X/DAY | 0 | 81 | MG | QD | ||||||||
| 126338091 | 12633809 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 1000 IU, 1X/DAY | 0 | 1000 | IU | QD | ||||||||
| 126338091 | 12633809 | 12 | C | OMEGA-3 ACIDS | OMEGA-3 FATTY ACIDS | 1 | 2 G, DAILY | 0 | 2 | G | |||||||||
| 126338091 | 12633809 | 13 | C | RAMIPRIL. | RAMIPRIL | 1 | 5 MG, 2X/DAY | 0 | 5 | MG | BID | ||||||||
| 126338091 | 12633809 | 14 | C | ADVIL | IBUPROFEN | 1 | AT BEDTIME | 0 | QD | ||||||||||
| 126338091 | 12633809 | 15 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | 0.5 MG EVERY MORNING, 1 MG EVERY EVENING | 0 | 1.5 | MG | |||||||||
| 126338091 | 12633809 | 16 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | 2 MG, 2X/DAY | 0 | 2 | MG | BID | ||||||||
| 126338091 | 12633809 | 17 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | 2 MG, DAILY | 0 | 2 | MG | |||||||||
| 126338091 | 12633809 | 18 | C | DOSTINEX | CABERGOLINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126338091 | 12633809 | 1 | Acromegaly |
| 126338091 | 12633809 | 4 | Acromegaly |
| 126338091 | 12633809 | 18 | Acromegaly |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126338091 | 12633809 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126338091 | 12633809 | Drug ineffective | |
| 126338091 | 12633809 | Dry skin | |
| 126338091 | 12633809 | Hypotension | |
| 126338091 | 12633809 | Injection site induration | |
| 126338091 | 12633809 | Injection site pruritus | |
| 126338091 | 12633809 | Injection site swelling | |
| 126338091 | 12633809 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126338091 | 12633809 | 1 | 201411 | 0 | ||
| 126338091 | 12633809 | 2 | 20141125 | 0 | ||
| 126338091 | 12633809 | 3 | 2009 | 0 | ||
| 126338091 | 12633809 | 4 | 201105 | 0 | ||
| 126338091 | 12633809 | 5 | 201207 | 0 | ||
| 126338091 | 12633809 | 6 | 2015 | 0 | ||
| 126338091 | 12633809 | 7 | 1999 | 0 | ||
| 126338091 | 12633809 | 9 | 2006 | 0 | ||
| 126338091 | 12633809 | 13 | 2008 | 0 | ||
| 126338091 | 12633809 | 16 | 2004 | 0 | ||
| 126338091 | 12633809 | 17 | 2014 | 0 |